Quantcast
Last updated on April 24, 2014 at 6:43 EDT

Latest Dennis S. Charney Stories

2014-04-16 23:01:31

Researchers from Mount Sinai Demonstrate Proof of Concept for New, Rapidly-Acting Pharmacotherapy for Treatment of PTSD New York, NY (PRWEB) April 16, 2014 For the first time, evidence that a single dose of IV-administered ketamine was associated with the rapid reduction of symptoms of post-traumatic stress disorder in patients with chronic PTSD was demonstrated in a proof-of-concept, randomized, double blind crossover study, undertaken by researchers at the Icahn School of Medicine at...

2014-04-08 23:02:24

Mount Sinai Team Cautiously Optimistic That Door Could Swing Open to A New Antidepressant Drug Class New York, NY (PRWEB) April 08, 2014 A research team from the Icahn School of Medicine at Mount Sinai published the first controlled evidence showing that an intranasal ketamine spray conferred an unusually rapid antidepressant effect –within 24 hours—and was well tolerated in patients with treatment-resistant major depressive disorder. This is the first study to show benefits with an...

2013-11-25 23:20:10

Selected from More Than 15 Million Scientists, World’s Most Powerful Researchers include Dr. Dennis S. Charney, Dr. Carlos Cordon-Cardo, Dr. Valentin Fuster, and Dr. Eric J. Nestler from Icahn School of Medicine at Mount Sinai. New York, New York (PRWEB) November 25, 2013 Icahn School of Medicine at Mount Sinai is pleased to announce four of its world-renowned physician-scientists are on the new list of the 400 most highly influential biomedical scientists in the world, published in the...

2013-11-25 23:01:32

Event Draws Hundreds of Scientists, Postdoctoral Students, and Team Leaders to Mount Sinai to Learn About Principles of Successful Teamwork in Science New York, NY (PRWEB) November 25, 2013 Hundreds of scientists and postdoctoral students packed the Stern Auditorium at the Icahn School of Medicine at Mount Sinai November 18th and 19th for the second annual SINAInnovations conference. This year’s conference explored how team science is critical for innovation and breakthroughs in...

2013-11-13 23:04:24

Major League Baseball’s EVP of Baseball Operations Joe Torre, New York State Health Commissioner Nirav Shah, MD, and US Navy’s Rear Admiral Scott P. Moore To Headline As Speakers New York, NY (PRWEB) November 13, 2013 The Icahn School of Medicine at Mount Sinai is hosting its second annual SINAInnovations event, and bringing together leaders from medicine, engineering, professional baseball, the performing arts, and the military to discuss the power of teamwork. “SINAInnovations:...

2013-10-29 23:01:32

Thought leaders from top medical centers, academia, and private industry discuss ways to harness the information revolution in health care, and use this vital data to improve the quality of patient care. New York, NY (PRWEB) October 29, 2013 Vast amounts of data from genomic sequencing and electronic health records (EHRs) have the potential to radically improve the health of individual patients, but first, institutions must learn how to manage the data, and adopt uniform standards in...

2013-10-24 23:02:41

Diane E. Meier, MD and Pamela Sklar, MD, PhD, recognized for outstanding professional achievement and commitment to service. New York, NY (PRWEB) October 24, 2013 Two Mount Sinai physicians have been elected to the Institute of Medicine (IOM) of the National Academy of Sciences (NAS), one of the highest honors in the fields of health and medicine. The two Mount Sinai honorees, recognized for outstanding professional achievement and commitment to service, are:...

2013-10-11 23:03:16

Dr. Kenny Plans to Build a Hub for Small Molecule Development and Next Generation Therapeutics New York, NY (PRWEB) October 11, 2013 Paul J. Kenny, PhD, has been named Chairman of the Dorothy H. and Lewis Rosenstiel Department of Pharmacology and Systems Therapeutics, and Ward-Coleman Professor at the Icahn School of Medicine at Mount Sinai, according to an announcement today by Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai, and...

2013-05-20 11:17:12

Drug associated with rapid antidepressant effect in largest clinical trial to date Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the Icahn School of Medicine at Mount Sinai. The antidepressant benefits of ketamine were seen within 24 hours, whereas traditional antidepressants can take days or weeks to demonstrate a...

2012-10-05 14:23:56

Raises hopes for new class of antidepressant Many chronically depressed and treatment-resistant patients experience immediate relief from symptoms after taking small amounts of the drug ketamine. For a decade, scientists have been trying to explain the observation first made at Yale University. Today, current evidence suggests that the pediatric anesthetic helps regenerate synaptic connections between brain cells damaged by stress and depression, according to a review of scientific...